Active Ingredient: BENDAMUSTINE HYDROCHLORIDE
Proprietary Name: BENDAMUSTINE HYDROCHLORIDE
Dosage Form; Route of Administration: POWDER; IV (INFUSION)
Strength: 25MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A205447
Product Number: 001
Approval Date: Feb 14, 2023
Applicant Holder Full Name: BRECKENRIDGE PHARMACEUTICAL INC
Marketing Status:
Prescription
Patent and Exclusivity Information
Active Ingredient: BENDAMUSTINE HYDROCHLORIDE
Proprietary Name: BENDAMUSTINE HYDROCHLORIDE
Dosage Form; Route of Administration: POWDER; IV (INFUSION)
Strength: 100MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A205447
Product Number: 002
Approval Date: Feb 14, 2023
Applicant Holder Full Name: BRECKENRIDGE PHARMACEUTICAL INC
Marketing Status:
Prescription
Patent and Exclusivity Information